0GRP.L - Biotage AB (publ)

LSE - LSE Delayed price. Currency in SEK
Currency in SEK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.73
52-week change 3N/A
S&P500 52-week change 314.65%
52-week high 3215.00
52-week low 3214.40
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 865.61M
% held by insiders 10.58%
% held by institutions 164.88%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.60
Trailing annual dividend yield 30.76%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023


Profit margin 15.57%
Operating margin (ttm)18.17%

Management effectiveness

Return on assets (ttm)7.92%
Return on equity (ttm)15.27%

Income statement

Revenue (ttm)1.54B
Revenue per share (ttm)23.35
Quarterly revenue growth (yoy)-6.50%
Gross profit (ttm)948M
Net income avi to common (ttm)240M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)-39.40%

Balance sheet

Total cash (mrq)426M
Total cash per share (mrq)6.46
Total debt (mrq)230M
Total debt/equity (mrq)13.63
Current ratio (mrq)2.74
Book value per share (mrq)25.58

Cash flow statement

Operating cash flow (ttm)295M
Levered free cash flow (ttm)178.98M